Matrix metalloproteinase‐9 (MMP9) drives ovarian cancer progression. Using MMP9‐null cells (M9‐KO) created from ovarian cancer cells, we found MMP9 loss did not block Epidermal Growth Factor (EGF)‐driven E‐cadherin dissolution or EMT but delayed and reduced EGF‐driven membrane protrusions. Transient MMP9 re‐expression drove membrane protrusion.
Claire Strauel +8 more
wiley +1 more source
Unlocking patient insights: a prospective study on patient reported outcome measures in thoracic surgery. [PDF]
Andreas MN +10 more
europepmc +1 more source
Systematic review of patient-reported outcome item libraries in cancer research: an EORTC Quality of Life Group study. [PDF]
Peacock R +5 more
europepmc +1 more source
Development and validation of the dysarthria impact scale: a patient-reported outcome for motor speech disorders. [PDF]
Vogel AP +5 more
europepmc +1 more source
Patient-Reported Outcome Measures in Fetal Medicine: A Pilot Feasibility Study. [PDF]
Crombag NMTH +9 more
europepmc +1 more source
Patient-reported outcome and prognostic factors for survival in patients with metastases in soft tissue treated with palliative radiotherapy. [PDF]
Otto-Vollaard L +5 more
europepmc +1 more source
Impairment of Diverse Patient-Reported Outcome Measures in Patients with Takayasu Arteritis: A Cohort Study. [PDF]
Thakare DR +8 more
europepmc +1 more source
Related searches:
Patient‐reported outcomes and patient voices
Seminars in Dialysis, 2022AbstractOnline hemodiafilration (HDF) treatment may be associated with better quality of life due to improved clearance of middle‐molecular‐weight uremic toxins and hemodynamic stability in dialysis patients, in addition to better overall survival.
Asci, Gulay, Ok, Ercan
openaire +3 more sources

